The law passed the Nigerian national assembly in May 2013 but President Goodluck Jonathan resisted signing it until early January, doing so with little fanfare as he knew the likely firestorm it would provoke among Nigeria’s development partners.
by Njihia Mbitiru
Global Fund efforts to target key affected populations including sexual minorities in the fight against HIV may continue to face an uphill battle in sub-Saharan Africa, new studies have shown, because of prevailing stigma and marginalization even within existing programming.
The Global Fund will cease funding HIV treatment services operating in compulsory drug treatment centres in Viet Nam.
The Board of the Global Fund to Fights AIDS, Tuberculosis and Malaria has approved continued funding of up to $46.4 million for three applicants. The Board decision was announced on 26 November.
The Board’s approval followed recommendations from the Technical Review Panel (TRP) and the Secretariat, including the Grant Approvals Committee (GAC). See the table for a full breakdown.
There are just two years remaining on the clock for developing nations to achieve the Millennium Development Goals, including Goal Six, targeting the global fight against AIDS, TB and malaria.
At its meeting on 8–9 October, the Strategy, Investment and Impact Committee (SIIC) made decisions in four areas related to the new funding model (NFM): awarding of incentive funding, managing unfunded quality demand, health systems strengthening and TB/HIV collaboration. This article provides details.
The Eurasian Harm Reduction Network (EHRN) has submitted a draft project concept to the Global Fund for review by the Secretariat and the Technical Review Panel (TRP) prior to submitting a full concept note. EHRN is the applicant for a regional initiative in Eastern Europe and Central Asia (EECA) on HIV and harm reduction. This is part of the transition phase of the new funding model (NFM).
The people involved in the Global Fund, and in global health generally, “are at an historic moment when the confluence of scientific advancement, epidemiological intelligence and experience from more than a decade of implementation come together to offer the opportunity to end three plagues as public health threats.”
The $278.9 million in early applicant funding approved for HIV in Zimbabwe will be combined with existing funding from a Round 8 HIV grant. The principal recipient (PR) for this grant is the United Nations Development Programme.
The Global Fund provided a narrative to explain the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the new funding. This article provides a summary of the comments.